LightPath Technologies (NASDAQ: LPTH) and TearLab (OTCMKTS:TEAR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.
Earnings and Valuation
This table compares LightPath Technologies and TearLab’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|LightPath Technologies||$28.37 million||2.12||$7.70 million||$0.32||7.66|
|TearLab||$28.01 million||0.13||-$19.92 million||($2.98)||-0.21|
This is a summary of current ratings for LightPath Technologies and TearLab, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
LightPath Technologies currently has a consensus price target of $2.80, indicating a potential upside of 14.29%. TearLab has a consensus price target of $5.75, indicating a potential upside of 812.41%. Given TearLab’s higher probable upside, analysts plainly believe TearLab is more favorable than LightPath Technologies.
Institutional & Insider Ownership
32.6% of LightPath Technologies shares are owned by institutional investors. Comparatively, 12.2% of TearLab shares are owned by institutional investors. 12.7% of LightPath Technologies shares are owned by insiders. Comparatively, 12.0% of TearLab shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
LightPath Technologies has a beta of -0.49, suggesting that its stock price is 149% less volatile than the S&P 500. Comparatively, TearLab has a beta of 2.92, suggesting that its stock price is 192% more volatile than the S&P 500.
This table compares LightPath Technologies and TearLab’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
LightPath Technologies beats TearLab on 9 of the 12 factors compared between the two stocks.
About LightPath Technologies
LightPath Technologies, Inc. is a manufacturer and integrator of families of precision molded aspheric optics, fiber-optic collimator, GRADIUM glass lenses and other optical materials used to produce products that manipulate light. The Company designs, develops, manufactures and distributes optical components and assemblies utilizing the optical processes and manufacturing technologies. The Company also performs research and development for optical solutions for the traditional optics markets and communications markets. The Company’s products are incorporated into a range of applications by its customers in various industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors.
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor’s office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Receive News & Ratings for LightPath Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LightPath Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.